Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

CHIR

Chiron (CHIR)

Chiron (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CHIR
DatumZeitQuelleÜberschriftSymbolFirma
21/06/200616h50PR Newswire (US)Bayer Diagnostics Receives FDA Approval for First Fully-Automated Human Immunodeficiency Virus (HIV) Antibody TestNASDAQ:CHIRChiron (MM)
19/04/200618h11Business WireChiron Shareholders Approve Novartis AcquisitionNASDAQ:CHIRChiron (MM)
13/04/200600h54PR Newswire (US)Standard & Poor's Announces Changes to U.S. IndicesNASDAQ:CHIRChiron (MM)
12/04/200602h16PR Newswire (US)/C O R R E C T I O N -- NASDAQ/NASDAQ:CHIR
12/04/200601h32PR Newswire (US)Akamai Technologies, Inc. to Join the NASDAQ-100 Index Beginning April 20, 2006NASDAQ:CHIRChiron (MM)
11/04/200614h00Business WireChiron Announces Initiation of Phase 1 Trial for CHIR-265 In Melanoma; Clinical Testing of Novel Oncology Compound Begins in PaNASDAQ:CHIRChiron (MM)
05/04/200622h05Business WireProxy Advisory Services Recommend Shareholders Vote in Favor of Chiron's Amended Merger Agreement with NovartisNASDAQ:CHIRChiron (MM)
03/04/200618h22Business WireChiron Announces Amended Merger Agreement with Novartis; Novartis to Acquire All Outstanding Chiron Shares for $48.00 Per ShareNASDAQ:CHIRChiron (MM)
31/03/200607h45Business WireChiron Statement on Recommendations by Proxy Advisory ServicesNASDAQ:CHIRChiron (MM)
16/03/200615h00Business WireChiron Recalls and Withdraws MORUPAR(R) MMR Vaccine from Italian and Developing World Markets -- Chiron Also Revises 2005 AdjusNASDAQ:CHIRChiron (MM)
15/03/200622h27Business WireChiron Response to ValueAct LetterNASDAQ:CHIRChiron (MM)
02/03/200619h30Business WireCORRECTING and REPLACING Chiron Schedules Special Meeting of Stockholders to Approve Merger With NovartisNASDAQ:CHIRChiron (MM)
02/03/200614h30Business WireChiron Schedules Special Meeting of Stockholders to Approve Merger With NovartisNASDAQ:CHIRChiron (MM)
24/02/200622h02Business WireChiron Confirms Proposed Purchase of BETASERON Assets by Schering AG Under Change-in-Control OptionNASDAQ:CHIRChiron (MM)
24/02/200622h01Business WireChiron Announces Pandemic Influenza Vaccine Contract with the UK Government; Chiron Submits Pandemic Influenza Vaccine ``Mock-UNASDAQ:CHIRChiron (MM)
24/02/200622h01Business WireChiron Updates Delivery Expectations for U.S. Government H5N1 Vaccine Stockpile ContractNASDAQ:CHIRChiron (MM)
07/02/200614h00Business WireChiron Announces Termination of SEC InvestigationNASDAQ:CHIRChiron (MM)
07/02/200603h00Business WireChiron Receives European Commission Approval for Proposed Merger With NovartisNASDAQ:CHIRChiron (MM)
02/02/200614h00Business WireChiron Foundation Awards Grants to National Organizations Promoting Improved Quality of Life for Cancer and Lung Transplant PatiNASDAQ:CHIRChiron (MM)
31/01/200622h01Business WireChiron Reports 2005 Adjusted Earnings of $1.34 Per Share, GAAP Earnings of $0.97 Per Share; FLUVIRIN(R) Influenza Virus VaccineNASDAQ:CHIRChiron (MM)
23/01/200622h33Business WireCubicin(R) Granted Marketing Approval in Europe; First-in-Class Antibiotic Approved for Treatment of Complicated Skin and Soft-TNASDAQ:CHIRChiron (MM)
23/01/200622h00PR Newswire (US)ArcaEx Tech 100 Index(R) Announces Change to Index ComponentsNASDAQ:CHIRChiron (MM)
17/01/200614h00Business WireChiron to Release Earnings on Tuesday, January 31, 2006; Conference Call/Audio Webcast to FollowNASDAQ:CHIRChiron (MM)
05/01/200614h00Business WireChiron to Present at 24th Annual JPMorgan Healthcare ConferenceNASDAQ:CHIRChiron (MM)
05/01/200614h00Business WireChiron Foundation Awards Grants to Seven Organizations Committed to Fighting Global Health ThreatsNASDAQ:CHIRChiron (MM)
31/10/200511h02Business WireChiron Announces Merger Agreement with Novartis; Novartis to Acquire Outstanding 58 Percent of Chiron Shares for $45.00 Per SharNASDAQ:CHIRChiron (MM)
28/10/200515h00Business WireChiron Announces Promising Data from Clinical Study of Adjuvanted Avian Influenza Vaccine; Results Confirm Previous Clinical StuNASDAQ:CHIRChiron (MM)
27/10/200519h46Business WireChiron to Supply United States with Pandemic Influenza Vaccine for Stockpile; Contract with U.S. Department of Health & Human SeNASDAQ:CHIRChiron (MM)
25/10/200522h00Business WireChiron Reports Third-Quarter 2005 Adjusted Earnings of $0.38 per Share, GAAP Earnings of $0.27 per ShareNASDAQ:CHIRChiron (MM)
25/10/200515h00Business WireChiron Initiates U.S. Phase I/II Study of Influenza Cell Culture VaccineNASDAQ:CHIRChiron (MM)
 Showing the most relevant articles for your search:NASDAQ:CHIR